Evidence map›Paper›PMID 38586471›Full record

ArticleJournal of virus eradication2024

Mass immunisation to eradicate Japanese encephalitis: Real-world evidence from Guizhou Province in 2005-2021.

Wan-Xue Zhang, Suye Zhao, Chunliu Pan, Yiguo Zhou, Chao Wang, Liping Rui, Juan Du, Ting-Ting Wei, Ya-Qiong Liu, Ming Liu and 2 more

Abstract read
In one paragraph

Article in Journal of virus eradication, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wan-Xue ZhangCenter for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China.
Suye ZhaoInstitute for Immunization Program, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China.
Chunliu PanGuiyang Center for Disease Control and Prevention, Guiyang, China.
Yiguo ZhouCenter for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China.
Chao WangDepartment of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing, China.
Liping RuiInstitute for Immunization Program, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China.
Juan DuCenter for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China.
Ting-Ting WeiCenter for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China.
Ya-Qiong LiuDepartment of Laboratorial Science and Technology & Vaccine Research Center, School of Public Health, Peking University, Beijing, China.
Ming LiuInstitute for Immunization Program, Guizhou Provincial Center for Disease Control and Prevention, Guiyang, China.
Qing-Bin LuCenter for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China.
Fuqiang CuiCenter for Infectious Disease and Policy Research & Global Health and Infectious Diseases Group, Peking University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To explore epidemiological changes of Japanese encephalitis (JE) in a long-time span and evaluate the impact of mass immunisation. Method: Data on JE cases from hospitals and the county Centers for Disease Control and Prevention in Guizhou Province was collected between 2005 and 2021. Epidemiological changes were analyzed according to a series of policy implementations and the coronavirus disease 2019 (COVID-19) pandemic. Results: A total of 5138 JE cases and 152 deaths were reported in Guizhou Province during 2005-2021. The average incidence and case fatality rates were 0.83/100,000 and 2.96%, respectively. The JE prevalence showed a declining trend over the years with the reduced incidence gap between age groups and narrowing of the high-epidemic regions. During the COVID-19 pandemic, the JE activity reached its nadir in 2020. The inclusion in the Expanded Program on Immunization of the JE vaccine and catch-up immunisations showed a significant impact on the JE declining incidence rate. Conclusions: The implementation of JE immunisation programs has played a crucial role in controlling its spread. Continued efforts should be made to maintain high coverage of the JE vaccine and strengthen disease surveillance systems, ensuring JE effective control and eventual elimination.

Indexed as

COVID−19EpidemiologyJapanese encephalitisVaccine

Identifiers

PMID38586471
PMCPMC10998223

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.